首页 | 本学科首页   官方微博 | 高级检索  
     


Metabolomic Tools for Secondary Metabolite Discovery from Marine Microbial Symbionts
Authors:Lynsey Macintyre  Tong Zhang  Christina Viegelmann  Ignacio Juarez Martinez  Cheng Cheng  Catherine Dowdells  Usama Ramadan Abdelmohsen  Christine Gernert  Ute Hentschel  RuAngelie Edrada-Ebel
Affiliation:1.Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, UK; E-Mails: (T.Z.); (C.V.); (I.J.M.); (C.D.);2.Department of Botany II, Julius-von-Sachs Institute for Biological Sciences, University of Würzburg, Julius-von-Sachs-Platz 3, D-97082 Würzburg, Germany; E-Mails: (C.C.); (U.R.A.); (C.G.); (U.H.)
Abstract:Marine invertebrate-associated symbiotic bacteria produce a plethora of novel secondary metabolites which may be structurally unique with interesting pharmacological properties. Selection of strains usually relies on literature searching, genetic screening and bioactivity results, often without considering the chemical novelty and abundance of secondary metabolites being produced by the microorganism until the time-consuming bioassay-guided isolation stages. To fast track the selection process, metabolomic tools were used to aid strain selection by investigating differences in the chemical profiles of 77 bacterial extracts isolated from cold water marine invertebrates from Orkney, Scotland using liquid chromatography-high resolution mass spectrometry (LC-HRMS) and nuclear magnetic resonance (NMR) spectroscopy. Following mass spectrometric analysis and dereplication using an Excel macro developed in-house, principal component analysis (PCA) was employed to differentiate the bacterial strains based on their chemical profiles. NMR 1H and correlation spectroscopy (COSY) were also employed to obtain a chemical fingerprint of each bacterial strain and to confirm the presence of functional groups and spin systems. These results were then combined with taxonomic identification and bioassay screening data to identify three bacterial strains, namely Bacillus sp. 4117, Rhodococcus sp. ZS402 and Vibrio splendidus strain LGP32, to prioritize for scale-up based on their chemically interesting secondary metabolomes, established through dereplication and interesting bioactivities, determined from bioassay screening.
Keywords:metabolomics   dereplication   symbiotic bacteria   mass spectrometry   NMR   multivariate analysis   metabolic profiling
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号